| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.27 | 2e-05 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.19 | 0.004 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.098 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.099 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.099 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.092 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.069 | 0.3 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.06 | 0.4 |